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Introduction: The aim of this randomized clinical trial was to compare the histologic pulp 
tissue response to one-step direct pulp capping (DPC) and miniature pulpotomy (MP) with 
mineral trioxide aggregate (MTA) after application of dexamethasone in healthy human 
premolars. Methods and Materials: Forty intact premolars from 10 orthodontic patients, were 
randomly chosen for DPC (n=20) or MP (n=20). In 10 teeth from each group, after exposure 
of the buccal pulp horn, topical dexamethasone was applied over the pulp. In all teeth the 
exposed/miniaturely resected pulp tissue was covered with MTA and cavities were restored 
with glass ionomer. Teeth vitality was evaluated during the next 7, 21, 42, and 60 days. Signs 
and/or symptoms of irreversible pulpitis or pulp necrosis were considered as failure. 
According to the orthodontic schedule, after 60 days the teeth were extracted and submitted 
for histological examination. The Kruskal-Wallis and Fisher’s exact tests were used for 
statistical analysis of the data (P=0.05). Results: Although dexamethasone specimens showed 
less inflammation, calcified bridge, pulpal blood vasculature, collagen fibers and granulation 
tissue formation were not significantly different between the groups (P>0.05). Conclusion: 
Topical dexamethasone did not hindered pulp healing but reduced the amount of underlying 
pulpal tissue inflammation after DPC and MP in healthy human premolars.  
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Introduction 
wing to defense reactions and reparative procedures of 
pulp-dentin complex to noxious stimuli, preservation of 
the vitality of this complex is absolutely critical for the survival 
of a tooth [1, 2]. The aim of different vital pulp therapy (VPT) 
techniques including direct pulp capping (DPC), is to seal the 
pulp wound, induce odontoblast-like cell differentiation, and 
stimulate dentin secretion and mineralization [3]. In 2012, 
Asgary and Ahmadyar [4, 5] hypothesized that miniature 
pulpotomy (MP) procedure will result in improved treatment 
outcome compared to DPC.  
In MP procedure, the infected dentin chips and damaged 
pulp tissue, especially the injured odontoblast cell layer, will be 
removed following caries exposure which is more confident in 
comparison with DPC [6]. 
Pulp tissue capping with biocompatible/bioinductor 
materials can stimulate the formation of mineralized tissues at 
the exposure site [7]. Several different capping materials to date 
were introduced meeting certain objectives of VPT. Mineral 
trioxide aggregate (MTA) has been proposed as material of 
choice for DPC procedures instead of calcium hydroxide 
because of its clinically easier use, less pulpal inflammation, and 
more predictable hard tissue barrier formation [8, 9]. Success of 
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Figure 1. The CONSORT flow diagram of the study 
 
VPT in management of cariously exposed vital permanent 
teeth has been shown [10, 11]. 
Degeneration or necrosis of dental pulp may be a direct 
consequence of chronic inflammation in the underlying pulpal 
tissue. Since the first application of topical steroids in 1958 [12], 
various research studies investigated possible effects of 
corticosteroids application on dental pulp tissue [13-18]. 
Although relief of symptoms and continued positive response to 
vitality tests in chronically inflamed pulps were shown for a 
steroid containing capping agent, Ledermix (Ledermix; Lederle 
Pharmaceuticals, Wolfratshausen, Germany) [19]. However, 
uncertain resolution of pulpal inflammation [20] and 
unpredictable results of this agent were reported [21, 22].  
The anti-inflammatory effect of corticosteroids is well-
known but cannot be tested in a cell culture systems. Direct 
application of dexamethasone to the pulpal tissues may affect the 
underlying tissue inflammation and reparative events leading to 
tissue healing.  
To our knowledge, no clinical study has been published 
about probable effects of direct application of dexamethasone to 
human dental pulp during DPC and/or MP procedures. Thus 
the purpose of this prospective randomized clinical trial was to 
compare the histologic pulp tissue response following DPC and 
MP using MTA with or without application of dexamethasone 
in healthy human premolars. 
Materials and Methods 
This randomized, double-blind, placebo-controlled, parallel-
group study was conducted with volunteers recruited from the 
pool of orthodontic patients at Mashhad Dental School. The 
study protocol was approved by the Mashhad University of 
Medical Sciences Ethical Committee and was registered at 
ClinicalTrials.gov (Identifier: NCT02574468). 
All healthy adult patients who had four intact fully developed 
maxillary and mandibular premolars needed to be extracted 
because of orthodontic treatment plan were considered eligible. 
Exclusion criteria were history of previous trauma, clinical 
and/or radiographic caries, restorations, periodontal problems, 
intake of anti-inflammatory medication before (over the last 
couple of weeks) and during the study, and known allergy 
and/or contraindications to corticosteroids. Of the 12 confirmed 
patients (48 teeth), 2 patients (8 teeth) refused to take part in the 
study. A total of 40 teeth from 10 patients (18-30 year old 
patients with an average of 24 years) were included in this 
clinical trial and randomly assigned to the test groups (Figure 1). 
After giving thorough and careful explanation of the study, 
verbal and written informed consent was acquired from all 
patients or their parents. 
Clinical procedures 
Using simple randomization procedures (computerized random 
numbers), forty intact premolars were randomly assigned to 
each of 4 treatment groups (n=10) including DPC, MP, 
DPC+dexamethasone and MP+dexamethasone.  
After administration of local anesthesia with 3% plain 
mepivacaine (Septodont, Cedex, France), rubber dam was 
applied and tooth surface was disinfected with 2% chlorhexidine 
gluconate. Occlusal cavity was prepared using high speed 
diamond fissure bur and buccal pulp horn was mechanically  
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Figure 2. A) Complete calcified bridge formed (asterisk) following 
DPC (100×); B) A 400× view of the same tooth, note the presence of 
macrophages (arrow) as a reaction to the capping material around the 
blood vessels; C) Secondary dentin (SD); D) Odontoblast-like cells in 
odontoblastic layer (quad arrow) 
 
Figure 3. A) Incomplete calcified bridge formation (asterisk) after DPC. 
Note the pulp (P) and secondary dentin (SD) (40×); B) Presence of 
Macrophages and histocytes (arrows) reflects tissue reaction to the 
capping material (400×) 
exposed (approximately 1 mm in diameter) using a sterile high 
speed carbide round bur. In MP groups, the depth of penetration 
to the pulp was 2 mm. All of the cavity preparation procedures 
were intermittently performed under copious water coolant and 
light hand pressure. Using a sterile 5.25% NaOCl-soaked cotton 
pellet, bleeding from the exposure site was controlled and the 
cavity was rinsed with 2 mL of sterile saline.  
For blinding the practitioner to the materials, 
dexamethasone (Sigma, La Verpillere, France) and distilled 
water were held in identical light proof syringes and numbered 
for each tooth according to the randomization schedule. The 
concentration/dose of dexamethasone applied was 10-8 M. 
Each tooth was assigned an order number and its pulpal wound 
received the solution in the corresponding prepacked syringe  
 
Figure 4. A) Normal odontoblastic layer (Ol) and unchanged collagen 
fibers. Note the pulp (P) and secondary dentin (SD) (100×); B and C) 
Complete calcified bridge formation (asterisks) following MP. Note the 
increased vascularity (arrows). (40×); D) A 100× view of the same tooth 
represents the increased pulpal vascularity under the capping material 
 
Figure 5. A) Complete calcified bridge formed (asterisks) after DPC 
with dexamethasone. Note the pulp (P) and secondary dentin (SD) 
(40×); B) An increase in cellular population in the odontoblastic layer 
(Ol) (100×); C) chronic inflammation; D) Odontoblast-like cells (400×) 
prior to sealing off the exposure site with white ProRoot MTA 
(Dentsply, Tulsa Dental, Tulsa, OK, USA); MTA was mixed 
according to the manufacturer's directions and a wet cotton 
pellet was placed over the material for 10 min. Eventually, the 
coronal cavity was restored with light-cured resin modified 
glass ionomer (Fuji II LC; GC Corporation, Tokyo, Japan) 
and cured for 40 sec using a curing light. Pulp and periapical 
status were clinically (7, 21, 42, and 60 days) and 
radiographically evaluated (42, and 60 days) during the study. 
Clinical and radiographic signs and/or symptoms of 
irreversible pulpitis or pulp necrosis were considered as 
treatment failure. After sixty days, teeth were extracted 
atraumatically and prepared for submission to the oral 
pathology department. 
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Figure 6. A) Complete calcified bridge formation (asterisk) after MP with 
dexamethasone (40×); B) Increased vascularity (arrows) of the pulp tissue 
(40×); C) Remarkable fibrous connective tissue formation and a decrease 
in pulp tissue cellularity (100×); D) Presence of chronic inflammatory cells 
(curved arrows) and multinucleated giant cells (notched arrow) represents 
pulp tissue reaction to the capping material (400×) 
Histological procedures 
Subsequent to extraction, apical one third of the tooth roots were 
immediately cut using high speed fissure burs and the teeth were 
immersed in a 10% neutral formalin solution (pH=7.4) for 2 
weeks. They were decalcified in 10% nitric acid for 2 weeks. The 
decalcified specimens were washed in distilled water, 
dehydrated in an ascending ethanol series, and embedded in 
paraffin. Four-mµ thick buccolingual serial sections were 
prepared parallel to the tooth long axis and stained with 
Hematoxylin-eosin. Specimens were coded and submitted to the 
oral pathology department for histologic assessment of hard 
tissue barrier formation (pattern and continuity), foreign body 
reaction (FBR) to the capping material, type and status of 
inflammation, changes in collagen content and vasculature and 
granulation tissue formation (GTF).  
An experienced independent pathologist that was blind to 
the treatment procedure did the histologic evaluation by a light 
microscope (Leica BME, USA) linked to a digital camera 
(Axiocam ERc5s; Zeiss, G€ottingen, Germany) under 40, 100, 
and 400× magnifications.  
Statistical analysis 
The data was statistically analyzed using the Kruskal-Wallis and 
Fisher Exact test. The SPSS software (SPSS version 9.0, SPSS, 
Chicago, IL, USA) served for calculating statistical means and 
statistical significance was set at 0.05. 
Results 
None of the participants reported analgesic intake due to post-
operative pain and discomfort. No radiographic signs of PDL 
widening or periapical pathosis were detected. Eventually, all 
specimens were attainable for microscopic assessment. GTF was 
not reported for any of the specimens. Calcified bridge 
formation was observed in all specimens (Figures 2 to 6). Pattern 
of calcified bridge was not significantly different between two 
treatment procedures (DPC and MP) (P>0.05). Topical 
dexamethasone did not have a significant effect on the pattern 
of calcified bridge formation (P>0.05). With regard to the 
continuity of the calcified bridge, MP showed more complete 
bridge formation than DPC regardless of dexamethasone 
application (Figure 3). However, the difference was not 
significant (P>0.05).  
FBR was observed in 4, 3, 3, and 2 specimens of DPC, MP, 
DPC+dexamethasone, and MP+dexamethasone, respectively. 
Although application of dexamethasone decreased the FBR 
following both DPC and MP procedures, the difference was not 
significant (P>0.05). 
No acute inflammation was reported after sixty days. Severe 
inflammation was not evident in any of the specimens. 
Regarding to the type and severity of pulpal inflammation, there 
was no significant difference between DPC and MP (P>0.05). 
Type and severity of pulpal inflammation remained untouched 
by addition of dexamethasone to both DPC and MP procedures 
(P>0.05). 
Discussion 
The aim of the current randomized clinical study was to 
compare the histologic pulp response to DPC and MP 
procedures using MTA with or without application of 
dexamethasone in healthy human premolars. Accordingly, the 
teeth were extracted and prepared for light microscopic 
examination after sixty days. 
In this study, MTA was used as capping material because of 
its benefits including significant biocompatibility [23], sealing 
ability [24], regenerative capabilities [25], push-out bond 
strength properties [26] and antibacterial characteristics [27]. 
Nair et al. [28, 29] confirmed preliminary results of animal 
models in humans and emphasized that MTA should be 
considered the new gold standard for pulp-capping treatments 
[8]. Moreover, in a clinical trial by Banava et al. [9] which also 
compared the histologic human pulp response to DPC with 
MTA or calcium hydroxide, it was stated that much more 
favorable outcomes can be expected with MTA. 
In the current study, one interesting finding was that there 
was no significant difference between MTA/DPC and MP 
concerning pulpal healing potential in mechanically exposed 
healthy human premolars.  
In the present study all teeth were symptom free throughout 
the study and calcified bridge was formed in all specimens 
providing more evidence for favorable outcome of one-step 
MTA-DPC and MP. The alkaline pH of MTA (10.2–12.5) seems 
responsible for the expression of the alkaline phosphatase, 
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favoring the mineralization process in contact with organic 
tissues [30].  
In case of pulpal exposures, inflammation is inevitable. 
Glucocorticoids block inflammatory mediator formation by 
inhibition of the arachidonic acid breakdown. In the current 
study, acute inflammatory reaction and severe inflammation 
were not reported for any of the specimens. Application of 
dexamethasone yielded more cases of “no inflammation” as well 
as less cases of “moderate inflammation” in both DPC and MP. 
However, the difference was not significant from statistical point 
of view. These findings are in line with previous studies showing 
limiting effect of corticosteroids on inflammatory reaction of 
dental pulp tissue [13, 15, 20, 31, 32] . 
Some previous animal studies reported comparable hard 
tissue formation and reparative dentinogenesis to control 
groups following systemic corticosteroid treatments [15, 33]. 
The present study demonstrated that calcified bridge formation 
and pulp tissue healing were not hindered by topical 
dexamethasone application during DPC and MP.  
In human dental pulp cell culture, low concentrations of 
fluocinolone acetonide enhanced type I collagen synthesis [16]. 
In the present study, less increase in collagen content was 
observed following the application of dexamethasone. One 
possible explanation for this discrepancy is that the effect of 
glucocorticoids on collagen synthesis seems to be dose-
dependent, and careful control of their release is of critical 
importance to successful pulp treatment [34]. 
Our results showed that vascular changes most probably 
remain untouched with topical dexamethasone application in 
DPC and MP. In a study, betamethasone application on the 
dentin reduced diameter and number of vessels in rat models 
[35]. Systemic damaging effects of corticosteroids seems highly 
unlikely in topical application during VPT procedures because 
of their small doses [36].  
This study can be criticized in that intact teeth with no 
history of chronic inflammation were examined, so the pulp 
tissue reaction to VPT procedures was optimal and may not be 
the same in case of previously diseased pulp. However, this 
interferes to a lesser extent in case of mechanically iatrogenic 
exposures. 
We recommend further studies using larger sample sizes to 
investigate the effects of corticosteroids on the outcome of VPT 
in cariously/traumatically exposed inflamed pulps. 
Conclusion 
Within the limitations of this study, DPC and MP were 
histologically and clinically successful treatment options for VPT 
in mechanically exposed human teeth. Using proper technique, 
pulpal healing is anticipated with both one step DPC and MP 
procedures. For pulp healing capacity and outcome of VPT, 
proper technique exceeds topical application of corticosteroids. 
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